Stephen Mahoney

Board Member

CEO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

VRDN

Current role

Board Member, CEO

1 call Latest call 2024-05-08

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Viridian Therapeutics, Inc.\DE (VRDN)	Chief Executive Officer	$700,000	—	$1,058,098	$4,381,713	$630,000	$6,438	$6,776,249
2024	Viridian Therapeutics, Inc.\DE (VRDN)	Chief Executive Officer	$650,000	—	—	—	$464,750	$2,704	$1,117,454
2023	Viridian Therapeutics, Inc.\DE (VRDN)	Chief Executive Officer	$112,847	$63,762	—	$12,302,728	—	$184	$12,479,521
2022	Viridian Therapeutics, Inc.\DE (VRDN)	Chief Executive Officer	—	—	—	—	—	—	—

Earnings-call appearances and filed executive appointments or departures, newest first.